Platelet-derived growth factor-induced vasodilatation in mesenteric resistance arteries by nitric oxide: Blunted response in spontaneous hypertension

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 2, 1999, Pages 223-228

  Takase, Hiroyuki ^a   Oemar, Barry S ^a   Pech, Michael ^b   Lüscher, Thomas F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Mesenteric resistance artery; PDGF; Spontaneously hypertensive rat; Vasodilatation; Wistar Kyoto rat

Indexed keywords

INDOMETACIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYPERTENSION; INDOMETHACIN; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASOCONSTRICTION; VASODILATION;

EID: 0032899804     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199902000-00007     Document Type: Article

References (30)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
2. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986;46:155-69.
3. Seifert RA, Hart CE, Phillips PE, et al. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 1989;264:8771-8.
4. Cunninghan LD, Brecher P, Cohen RA. Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta. J Clin Invest 1992;89:878-82.
5. Bar RS, Boes M, Booth BA, et al. The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 1989;124:1841-8.
6. Beitz JG, Kim I-S, Calabresi P, Frackelton ARJ. Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci U S A 1991;88:2021-5.
7. Berk BC, Alexander RW, Brock TA, Gimbrone JMA, Webb RC. Vasoconstriction: a new activity for platelet-derived growth factor. Science 1986;232:87-90.
8. Sauro MD, Thomas B. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s). J Pharmacol Exp Ther 1993;267:1119-25.
9. Sachinidis A, Locher R, Hoppe J, Vetter W. The platelet derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms. FEBS Lett 1990;275:95-8.
10. 9-bradykinin or α-thrombin in rabbit aortic rings. Br J Pharmacol 1992;105:959-67.
11. Lüscher TF, Vanhoutte PM. Monograph on the endothelium: modulator of cardiovascular function. 1st ed. Boca Raton, FL: CRC Press, 1990.
12. Lüscher TF, Vanhoutte PM. Antihypertensive therapy normalizes endothelium-dependent relaxations in salt-induced hypertension of the rat. Hypertension 1987;9(suppl III):193-7.
13. Dohi Y, Thiel MA, Bühler FR, Lüscher TF. Activation of endothelial L-arginine pathway in resistance arteries: effect of age and hypertension. Hypertension 1990;15:170-9.
14. Diederich D, Yang Z, Bühler FR, Lüscher TF. Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve the cyclooxygenase pathway. Am J Physiol 1990;258:H445-51.
15. Küng CF, Lüscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 1995;25:194-200.
16. Thiel MA, Bock AH, Bühler FR, Lüscher TF. Intra-luminal pressure modulates vascular contractility of perfused mesenteric resistance arteries. Am J Hypertens 1992;5:542-7.
17. Tesfamariam B, Halpern W. Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension 1988;11:440-4.
18. Dohi Y, Criscione L, Pfeiffer K, Lüscher TF. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994;24:372-9.
19. De Mey JG, Gray SG. Endothelium-dependent reactivity in resistance vessels. Prog Appl Microcirc 1985;88:181-7.
20. Watt PA, Thurston H. Endothelium-dependent relaxation in resistance vessels from the spontaneously hypertensive rats. J Hypertens 1989;7:661-6.
21. Wallenstein S, Zucker CL, Fleiss J. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
22. Lüscher TF, Aarhus LL, Vanhoutte PM. Indomethacin improves the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rat. Am J Hypertens 1990;3:55-8.
23. Bassett JE, Bowen-Pope DF, Takayasu M, Dacey RGJ. Platelet-derived growth factor does not constrict rat intracerebral arterioles in vitro. Microvasc Res 1988;35:368-73.
24. Hermiller JB, Finton CK, Goldstein RE, Feuerstein GZ. Platelet derived growth factor augments coronary blood flow in vivo [Abstract]. Circulation 1987;76(suppl IV):387.
25. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986;46:155-69.
26. Ogawa H, Yasue H, Misumi I, et al. Plasma platelet-derived growth factor levels in coronary circulation in unstable angina pectoris. Am J Cardiol 1992;69:453-6.
27. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
28. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial, nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990;101:746-52.
29. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-68.
30. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987;92:181-7.